Nutex Health (NUTX) Cash from Investing Activities (2010 - 2026)

Nutex Health has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$1.2 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$1.2 million, down 1776.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.4 million (down 29.21% YoY), and the FY2025 annual result was -$5.2 million, up 6.49% from the prior year.
• Cash from Investing Activities came in at -$1.2 million for Q1 2026 at Nutex Health, up from -$5.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $7.9 million in Q4 2022 to a low of -$8.6 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$1.2 million (2026), against an average of -$1.6 million.
• Across the five-year window, Cash from Investing Activities soared 166.95% in 2022 and tumbled 1776.56% in 2026, its largest moves.
• Nutex Health's Cash from Investing Activities stood at $7.9 million in 2022, then slumped by 89.02% to $865481.0 in 2023, then sank by 485.45% to -$3.3 million in 2024, then sank by 52.04% to -$5.1 million in 2025, then jumped by 76.32% to -$1.2 million in 2026.
• The last three Cash from Investing Activities figures came in at -$1.2 million (Q1 2026), -$5.1 million (Q4 2025), and -$302000.0 (Q3 2025), per Business Quant data.